Becton, Dickinson and Company Stock Price and Value Analysis

Should you buy Becton, Dickinson and Company stock? (NYSE:BDX). Let's see how it does in our automated value investing analysis system.

BDX Free Cash Flow Trend

Free Cash Flow trendline for BDX
Free Cash Flow trendline for Becton, Dickinson and Company

Hmm, we can't give any reliable projection for Becton, Dickinson and Company's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

AdvantagesDisadvantages
  • This company is very stable.
  • This company has wild ups and downs.
  • This company has a low dividend yield.
  • This company is not making money.
  • This stock looks overpriced.

Inside the BDX Numbers

BDX Price
(Becton, Dickinson and Company stock price per share)
$248.33
PE Ratio versus Sector 328% higher than other Healthcare stocks
PE Ratio versus Industry 260% higher than other Medical Instruments & Supplies stocks
Cash Yield 2.97%
Free Cash Flow Jitter 2140%
Dividend Yield 1%

Is Becton, Dickinson and Company Stock on Sale?

Based on our analysis, we believe that you should not buy Becton, Dickinson and Company right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy BDX Stock?

Does Becton, Dickinson and Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.